B2 - Health technology assessments: A global overview
Auditorium 2
Organised by the FIP SIG on Pharmacy Practice Research in collaboration with FIP’s Health and Medicines Information Section
Chairs
Dalia Dawoud, Cairo University, Egypt and Victoria García-Cárdenas, FIP Pharmacy Practice Research Special Interest Group, AustraliaIntroduction
This session will provide an introduction to health technology assessment (HTA) and its role in supporting decision making about access to health technologies including digital applications and companion diagnostics. An overview of the HTA process and its different models will be given as well as examples of the different country cases.
Programme
- HTA: The “What?”, “Why?” and “How?”
Clémence Perraudin, Community Pharmacy Centre Department of Ambulatory Care and Community Medicine, Switzerland - Implementation and adoption of HTA around the world
Juan Carlos Rejon, Andalusian Agency for Health Technology Assessment (AETSA), Spain - HTA in action
Dyfrig Hughes, Bangor University, UK
Learning Objectives
At the end of this session, participants will be able to:
- To define health technology assessment and list steps involved in undertaking it.
- To explain the importance of assessing the value of new technologies before adopting them on a health-system level
Type of session: Knowledge-based
